Clinical trial
Ranibizumab for Edema of the Macula in Diabetes: a Phase 2 Study ( The Read-2 Study)
NCT00407381 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Ranibizumab for Edema of the Macula in Diabetes: a Phase 2 Study ( The Read-2 Study)
- Lead sponsor
- Johns Hopkins University
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- December 31, 2006
- Completion date
- August 31, 2011
- Enrollment
- 126 (actual)
- Sites
- 20
Conditions
As the registry lists them; a condition with its own page is linked.
diabetic macular edema